冷冻神经消融术与全膝关节置换术后患者疼痛、功能和睡眠改善相关:一项新真实世界登记研究的使用情况
该研究基于创新膝神经结局登记研究,纳入2021年9月至2024年2月期间接受单侧初次全膝关节置换术且术前无阿片类药物处方的患者,比较术前接受冷冻神经消融术与未接受者的结局。结果显示冷冻神经消融术组在6个月随访期内疼痛严重程度和睡眠障碍显著更低(P=0.046),功能改善呈趋势但未达统计学显著(P=0.061),且术后6个月内使用阿片类药物的可能性比对照组低72%(P<0.001)。
要点
- 术前冷冻神经消融术与全膝关节置换术后6个月疼痛严重程度和睡眠障碍显著降低相关(P=0.046)。
- 冷冻神经消融术组术后6个月使用阿片类药物的可能性比对照组低72%(P<0.001)。
- 功能改善呈趋势但未达统计学显著(P=0.061)。
核心结论
- 在未使用过阿片类药物的全膝关节置换术患者中,术前冷冻神经消融术与术后6个月疼痛改善、阿片类药物使用减少和睡眠障碍改善相关。
研究设计与样本
- 研究纳入2021年9月至2024年2月期间登记于创新膝神经结局登记研究的患者,随访6个月。
- 分析对象为接受单侧初次全膝关节置换术且术前无阿片类药物处方的患者,分为接受冷冻神经消融术组(80例)和未接受治疗的对照组(60例)。
- 采用广义线性混合效应回归模型比较冷冻神经消融术组与对照组,以P<0.05为显著。
主要发现
- 冷冻神经消融术组在6个月随访期内疼痛严重程度和睡眠障碍显著低于对照组(P=0.046)。
- 冷冻神经消融术组功能改善呈优于对照组的趋势,但未达统计学显著(P=0.061)。
- 冷冻神经消融术组术后6个月内使用阿片类药物的可能性比对照组低72%(P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total knee arthroplasty (TKA) is performed on approximately 790,000 patients annually in the United States and is projected to increase to 1.5 million by 2050. This study aimed at assessing the use of preoperative cryoneurolysis on patients undergoing TKA by analyzing: (1) pain severity; (2) opioid use; (3) functional status; and (4) sleep disturbance (SD) over 6 months following discharge. METHODS: Patients enrolled in the Innovations in Genicular Outcomes Registry between September 2021 and February 2024 were followed for 6 months. Our analyses included patients undergoing unilateral primary TKA with no preoperative opioid prescription, who either received cryoneurolysis, or did not. Baseline patient demographics were collected before TKA and tabulated. Pain management was assessed via the Brief Pain Inventory-Short Form instrument for pain severity. SD was measured using the patient-reported outcomes measurement information system questionnaire. Each outcome measure was assessed prior to TKA, weekly, and at monthly follow-up. Data were analyzed by a generalized linear mixed-effect regression model to compare cryoneurolysis versus control patients, with a P < .05 as significant. RESULTS: There were 80 patients who were treated with preoperative cryoneurolysis, while 60 control patients did not have treatment. Patients receiving cryoneurolysis experienced significantly lower pain severity and SD over the 6-month follow-up than control patients (P = .046). Cryoneurolysis was also associated with a trend toward greater functional improvement that did not reach statistical significance (P = .061). Further, patients who underwent cryoneurolysis were 72% less likely than control group patients to take opioids over 6 months following discharge (P < .001). CONCLUSIONS: Preoperative cryoneurolysis therapy in opioid-naive patients undergoing TKA is associated with improved pain, decreased opioid use, and improved SD for 6 months postoperatively. Cryoneurolysis, a nonopioid pain relief modality administered preoperatively, demonstrated substantial benefits in patients who underwent TKA.
引用
- Mont MA, Lin JH, Spitzer AI, et al. Cryoneurolysis Associated With Improved Pain, Function, and Sleep in Patients Following total Knee Arthroplasty: Use of a New Real-World Registry. J Arthroplasty. 2024. PMID: 38942249. doi:10.1016/j.arth.2024.06.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。